跳至主要内容
临床试验/NCT02794948
NCT02794948已完成1 期

Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency:Randomized, Double-blind, DHEA-controlled Trial

Guangzhou University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年4月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
48
试验地点
1
主要终点
Anti-Mullerian hormone

研究概览

简要总结

The purpose of this research is providing valuable traditional chinese medicine theory and formula in treating Primary Ovarian insufficiency.

详细描述

Primary ovarian insufficiency is a problem that is to be solved urgently in the field of reproductive endocrine. According to the basic theory of traditional Chinese Medicine and clinical experience, investigators developed a Chinese medicine formula(Hu yang yang kun,Hyyk). This research is designed according to the principle of randomized double blind control and evaluated the effectiveness and safety of Hyyk, hope to provide a kind of effective medicine in treating primary ovarian insufficiency.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Menstrual cycle change more than 7 days at least 2 times,amenorrhea less than 6 months.
  • Sex hormone:bFSH>10u/L;or E2>80pg/ml.
  • AMH<1ng/ml.
  • Informed consent and truthfully answer the question.

排除标准

  • Dose not meet the inclusion criteria.
  • Genital tract malformation,congenital germinal aplasia, uterine amenorrhea and so on organic disease.
  • Endocrine diseases such Polycystic ovary syndrome、hyperprolactinemia 、dysfunctional uterine bleeding、low gonadotropin menstrual disorders and hyperthyreosis
  • Autoimmune disease patients:Hashimoto's thyroiditis,SLE,Primary chronic adrenal cortical insufficiency,Asthenic bulbar paralysis,Arthritis deformans,Idiopathic thrombocytopenic purpura, type I diabetes and so on.
  • Someone who have the following gynecological operation history: oophorocystectomy,ovarian drilling,wedgeshaped oophorectomy,adnexectomy,tubal resection,ligation of oviduct,pelvic abscess surgery,uterine arterial embolization.
  • Someone who have used reproductive toxicity drugs: tripterygium wilfordii,tripterygium hypoglaucum hutch,chemotherapeutics and so on.
  • A family history of ovarian failure.
  • Have receive hormone therapy in recent 3 months.
  • Pregnant or lactating women.
  • with serious heart,liver and kidney disease
  • With severe psychiatric disorders .
  • Have participated in other clinical trials in 3 months.

研究组 & 干预措施

Chinese Medicine intervention

Experimental

Chinese medicine HuYang Yang Kun Formula 1 capsule every time per day for 3 day per month, DHEA(dehydroepiandrosterone) placebo 1 sack every time, twice a day for three months

干预措施: Chinese medicine granules (HuYang Yang Kun Formula) (Other)

Western intervention

Active Comparator

DHEA(dehydroepiandrosterone) 1 sack every time twice a day for three months. Chinese medicine formula granules placebo 1 capsule every time per day for 3 day per month.

干预措施: dehydroepiandrosterone (Dietary Supplement)

结局指标

主要结局

Anti-Mullerian hormone

时间窗: 1year

Anti-Mullerian hormone (AMH) is a gonadal hormone synthesized by granulose cells of the ovary and Sertoli cells of the testis. Anti-Mullerian hormone is used to facilitate the evaluation of intersex disorders and as a marker in ovarian reserve assessment in the infertility cases.

次要结局

  • Follicle stimulating hormone(1year)
  • Menopause rating scale(1year)
  • Menstrual Cycle(1year)
  • Estrogen(1year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验